Study guide

6.1 Prescription Requirements & Practitioner Authority

New York MPJE Pharmacy Jurisprudence Exam

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 About the NY MPJE Exam 1.2 Study Strategy & Federal vs. New York Law Hierarchy

2 Federal Pharmacy Law: Controlled Substances

2.1 Controlled Substances Act & DEA Scheduling 2.2 DEA Registration, Forms & Security 2.3 Federal Food, Drug, and Cosmetic Act (FDCA)

3 Federal Pharmacy Law: Privacy & Supply Chain

3.1 HIPAA & Patient Privacy 3.2 OBRA '90, Medicare/Medicaid & DUR 3.3 DSCSA & Drug Supply Chain Integrity

4 Area 1a: NYSED, Board & Pharmacist Licensure

4.1 NYSED Office of the Professions, Board of Pharmacy & Education Law Article 137 4.2 Pharmacist Licensure: Education, NAPLEX/MPJE & Internship 4.3 License by Endorsement, Renewal & Continuing Education

5 Area 1b: Interns, Technicians & Discipline

5.1 Pharmacy Interns & Limited Permits 5.2 Registered Pharmacy Technicians (RPhT) & Supervision Ratios 5.3 Professional Misconduct, Discipline & Impaired Practitioner Programs

6 Area 2a: Prescribing, Controlled Substances & Collaborative Practice

6.1 Prescription Requirements & Practitioner Authority 6.2 Controlled Substance Prescribing & the NY EPCS Mandate 6.3 Refills & Authority Limitations 6.4 Collaborative Drug Therapy Management (§6801-a) & Non-Patient-Specific Orders

7 Area 2b: Counseling, Immunization & Public Health

7.1 Patient Counseling & Documentation 7.2 Pharmacist Immunization Authority 7.3 Naloxone Access & Public Health Programs 7.4 Patient Confidentiality & Pharmacy Records

8 Area 3a: Verification, Transfers & DUR/I-STOP

8.1 Legitimate Medical Purpose & Corresponding Responsibility 8.2 Prescription Transfers Between Pharmacies 8.3 Prospective DUR & the I-STOP PMP Registry 8.4 Refill Exceptions & Emergency Dispensing

9 Area 3b: Labeling, Packaging & Substitution

9.1 Labeling of Dispensed Drugs 9.2 Packaging: PPPA & Child-Resistant Containers 9.3 Generic Substitution & Interchangeable Biologics (§6816-a) 9.4 OTC, Behind-the-Counter & Restricted Nonprescription Sales

10 Area 4a: Records, Inventories & Delivery

10.1 Ordering, Acquisition & Distribution Records 10.2 Recordkeeping, Storage & Handling 10.3 Controlled Substance Inventories & BNE Registration 10.4 Delivery & Mail-Order Dispensing

11 Area 4b: Compounding, Central Fill & Facilities

11.1 Compounding: Non-Sterile, Sterile & Hazardous Drugs 11.2 Central Fill, Centralized Processing & Shared Pharmacy Services 11.3 Automated Dispensing & Telepharmacy 11.4 Pharmacy Establishment Registration, Inspections & Discipline

12 Test-Day Strategy & Final Review

12.1 When New York Law Is Stricter Than Federal Law 12.2 Test-Day Strategy & Common Traps

6.1 Prescription Requirements & Practitioner Authority

Key Takeaways Explain This Topic AI

New York requires the quantity of dosage units to appear in both numerical and spelled-out word form on the paper Official New York State Prescription (ONYSRx) for a controlled substance, per 10 NYCRR §§80.67(5) and 80.69(5) — electronic prescriptions are exempt from this dual-format rule.

Nurse practitioners may prescribe Schedule II-V controlled substances only within the clinical specialty for which they are certified by the State Education Department, and gain independent practice authority after 3,600 qualifying practice hours under the NP Modernization Act.

A physician may supervise no more than 6 physician assistants in a private practice setting under Education Law §6542; this numeric cap does not apply to PAs employed in a hospital.

Emergency oral Schedule II prescriptions require the prescriber to deliver a written or electronic follow-up to the pharmacist within 72 hours in New York — stricter than the federal 7-day standard under 21 CFR §1306.11(d).

Education Law §6802 excludes facsimile transmission from the definition of an 'electronic prescription'; a prescriber may never use a 'failover fax' as a substitute when an e-prescription fails to transmit.

Last updated: July 2026

Legal Framework for Prescribing in New York

New York pharmacy practice is governed primarily by Education Law Article 137 (the Pharmacy Practice Act, codified at N.Y. Education Law §§6800 et seq.) together with Public Health Law (PHL) Article 33 (the New York State Controlled Substances Act). Implementing regulations sit in two places pharmacists must know: 8 NYCRR Part 63 (Rules of the Board of Regents / State Education Department governing pharmacy practice, including §63.6 on prescription requirements) and 10 NYCRR Part 80 (Department of Health regulations on controlled substances, including the Official New York State Prescription program). A prescription that satisfies DEA form requirements but omits a New York-specific element — such as the ONYSRx serial number or the written-word quantity — is not a valid New York prescription, regardless of federal sufficiency.

Elements of a Valid Prescription

Under 8 NYCRR §63.6, every New York prescription — written, oral, or electronic — must include the patient's name and address, the date of issue, the drug name, strength, and quantity, directions for use, and the prescriber's name, address, telephone number, profession, and signature (or electronic signature). For controlled substances, the prescriber's DEA registration number is also required.

Two New York-specific wrinkles apply to the paper Official New York State Prescription (ONYSRx) form used for controlled substances:

Numeric and written-word quantity. Title 10 NYCRR §§80.67(5) and 80.69(5) require the quantity of dosage units to appear in both numerical and spelled-out word form on the ONYSRx — a tamper-resistance measure. This dual-format rule applies only to the paper ONYSRx form, not to electronic prescriptions.

Serialization. PHL §3338 requires that Official New York State Prescription forms be serialized by the Department of Health. Each serial number is an eight-character alphanumeric code that never contains a vowel. When pharmacies report dispensing data to the state's Prescription Monitoring Program registry, they use the placeholder ZZZZZZZZ for out-of-state or Veterans Affairs prescriptions and 99999999 for oral or faxed prescriptions, since those do not carry a state-issued serial number.

Who May Prescribe in New York

  • Prescriber Authority Key Scope Limits
  • Physician (MD/DO) Full prescriptive authority, all schedules None beyond professional standards

Nurse Practitioner (NP) Schedules II-V within certified specialty Independent practice available after 3,600 qualifying practice hours (NP Modernization Act); must hold own DEA number and register in the NYS Official Prescription Program

Physician Assistant (PA) Schedules II-V, to the extent delegated by supervising physician (PHL §3702) A physician may supervise no more than 6 PAs in private practice (Education Law §6542); no numeric cap for PAs employed in a hospital

  • Dentist Drugs within dental scope of practice No systemic prescribing outside dental treatment
  • Podiatrist Drugs within podiatric scope Limited to foot- and ankle-related treatment

Veterinarian Drugs for animal patients Categorically excluded from the EPCS mandate; may not prescribe for human use

A nurse practitioner's prescriptive authority for controlled substances is tied to the clinical specialty for which the NP is certified by the State Education Department — an NP certified in psychiatric mental health practice, for example, cannot use that DEA registration to prescribe outside psychiatric practice. A physician assistant may apply to the DEA for an individual "mid-level practitioner" registration number, but actual prescribing remains bounded by whatever the supervising physician delegates and by any additional limits the employing clinic or hospital imposes.

Oral, Written, and Electronic Forms

Electronic prescribing is now the default method for essentially all New York prescriptions (Section 6.2 covers the mandate in detail). Oral (telephoned) prescriptions remain lawful for non-controlled drugs and for Schedule III-V controlled substances; the receiving pharmacist must promptly reduce the order to writing, noting the prescriber's name, the date received, and that it was received orally.

Schedule II oral prescriptions are narrower still: they are lawful only in a genuine emergency, the quantity must be limited to what is needed to cover the emergency period, and — critically — New York requires the prescriber to deliver a written or electronic follow-up prescription to the pharmacist within 72 hours , not the 7 days federal law otherwise allows (10 NYCRR §80.68(c); see Section 6.3 for the full comparison).

Fax deserves a specific warning for the MPJE: Education Law §6802 excludes facsimile transmission from the statutory definition of an "electronic prescription." A manually signed ONYSRx that is faxed to the pharmacy under a documented exception may be acceptable, but a prescriber (or an intermediary such as a hub or EHR vendor) may never convert a failed electronic transmission into a fax as a workaround — that "failover fax" is treated as informational only, never as a valid prescription.

Applying the Rules

A pharmacist who receives a telephoned prescription from a podiatrist for a systemic antibiotic unrelated to any foot or ankle condition should recognize the order as outside the podiatrist's scope, regardless of how the prescription is transmitted. Similarly, a PA prescription for a Schedule II drug is only valid if the supervising physician's delegation specifically extends to Schedule II prescribing — the PA's individual DEA registration does not, by itself, establish that authority.